Trinity Biotech (TRIB) Operating Margin (2016 - 2024)
Historic Operating Margin for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to 72.61%.
- Trinity Biotech's Operating Margin fell 444600.0% to 72.61% in Q4 2024 from the same period last year, while for Dec 2024 it was 34.38%, marking a year-over-year increase of 132100.0%. This contributed to the annual value of 34.38% for FY2024, which is 132000.0% up from last year.
- Latest data reveals that Trinity Biotech reported Operating Margin of 72.61% as of Q4 2024, which was down 444600.0% from 16.88% recorded in Q3 2024.
- Over the past 5 years, Trinity Biotech's Operating Margin peaked at 28.38% during Q3 2020, and registered a low of 106.86% during Q2 2023.
- For the 5-year period, Trinity Biotech's Operating Margin averaged around 17.79%, with its median value being 14.44% (2022).
- In the last 5 years, Trinity Biotech's Operating Margin crashed by -948600bps in 2023 and then surged by 812900bps in 2024.
- Trinity Biotech's Operating Margin (Quarter) stood at 27.67% in 2020, then tumbled by -90bps to 2.88% in 2021, then tumbled by -1899bps to 51.87% in 2022, then soared by 46bps to 28.14% in 2023, then crashed by -158bps to 72.61% in 2024.
- Its Operating Margin was 72.61% in Q4 2024, compared to 16.88% in Q3 2024 and 25.58% in Q2 2024.